PL2968214T3 - Nowe kompozycje przeciwbólowe - Google Patents

Nowe kompozycje przeciwbólowe

Info

Publication number
PL2968214T3
PL2968214T3 PL14762748T PL14762748T PL2968214T3 PL 2968214 T3 PL2968214 T3 PL 2968214T3 PL 14762748 T PL14762748 T PL 14762748T PL 14762748 T PL14762748 T PL 14762748T PL 2968214 T3 PL2968214 T3 PL 2968214T3
Authority
PL
Poland
Prior art keywords
painkillers
new
new painkillers
Prior art date
Application number
PL14762748T
Other languages
English (en)
Inventor
Danguole Spakevicius
Heather Giles
Terry Farmer
Original Assignee
Newvapogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newvapogen, Inc. filed Critical Newvapogen, Inc.
Publication of PL2968214T3 publication Critical patent/PL2968214T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL14762748T 2013-03-15 2014-03-14 Nowe kompozycje przeciwbólowe PL2968214T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361792383P 2013-03-15 2013-03-15
US201361814485P 2013-04-22 2013-04-22
PCT/US2014/028169 WO2014143964A2 (en) 2013-03-15 2014-03-14 Novel analgesic compositions
EP14762748.3A EP2968214B1 (en) 2013-03-15 2014-03-14 Novel analgesic compositions

Publications (1)

Publication Number Publication Date
PL2968214T3 true PL2968214T3 (pl) 2021-11-02

Family

ID=51538291

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14762748T PL2968214T3 (pl) 2013-03-15 2014-03-14 Nowe kompozycje przeciwbólowe

Country Status (10)

Country Link
US (5) US9655867B2 (pl)
EP (2) EP3854389A1 (pl)
JP (4) JP6669645B2 (pl)
CN (3) CN112933036A (pl)
AU (4) AU2014227996B2 (pl)
CA (2) CA2906072C (pl)
DK (1) DK2968214T3 (pl)
ES (1) ES2873964T3 (pl)
PL (1) PL2968214T3 (pl)
WO (1) WO2014143964A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112933036A (zh) 2013-03-15 2021-06-11 维普詹尼克斯公司 新型镇痛组合物
ES2809458T3 (es) * 2014-07-17 2021-03-04 Pharmaceutical Manufacturing Res Services Inc Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata
EP3325063B1 (en) 2015-07-20 2022-10-05 Medical Developments International Limited Inhaler device for inhalable liquids
KR102574310B1 (ko) 2015-07-20 2023-09-05 메디컬 디벨롭먼츠 인터네셔널 리미티드 흡입가능한 액체를 위한 흡입기 장치
US20180200459A1 (en) 2015-07-20 2018-07-19 Medical Developments International Limited Inhaler device for inhalable liquids
US9554998B1 (en) 2015-08-04 2017-01-31 Damaso Fernandez Gines Composition of analgesic bioadhesive healing microspheres
CA3019582A1 (en) * 2016-03-31 2017-10-05 Smartech Topical, Inc. Delivery system
US11571526B2 (en) 2016-09-06 2023-02-07 Medical Developments International Limited Inhaler device for inhalable liquids
GB201706969D0 (en) * 2017-05-02 2017-06-14 Medherant Ltd Formulation
CN107693560A (zh) * 2017-09-13 2018-02-16 冯威 一种具有镇痛功能的药学组合物
CN113543773B (zh) * 2019-03-08 2023-07-14 塔罗制药工业有限公司 稳定的局部用非诺多泮组合物
CN110090197A (zh) * 2019-04-19 2019-08-06 广州芮一生物科技有限公司 一种可成膜的麻醉面膜膏
US20220347132A1 (en) * 2019-09-19 2022-11-03 Celista Pharmaceuticals Llc Sprayable liquid lidocaine solution
EP4054549A4 (en) * 2019-11-06 2023-12-06 Smartech Topical, Inc. TOPICAL FORMULATIONS OF CYCLO-OXYGENASE INHIBITORS AND THEIR USE
WO2021134029A1 (en) * 2019-12-24 2021-07-01 Ampersand Biopharmaceuticals, Inc. Topical nicotine for smoking cessation
WO2021162796A1 (en) * 2020-02-11 2021-08-19 Taro Pharmaceutical Industries Ltd. Compositions comprising desoximetasone and tazarotene
JP2024519493A (ja) * 2021-05-05 2024-05-14 スマーテック トピカル，インコーポレイテッド 局所ナプロキセン製剤及びそれらの使用
CN113289172B (zh) * 2021-05-31 2023-11-03 成都中医药大学附属医院 用于治疗急诊创伤性疼痛的芳香化甲氧氟烷吸入装置
WO2023217384A1 (en) 2022-05-13 2023-11-16 Laboratorios Gebro Pharma, S.A. Pharmaceutical composition for topical administration comprising a volatile anaesthetic

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3216897A (en) * 1961-11-02 1965-11-09 Air Reduction Injectable anesthetic
AR206458A1 (es) * 1975-03-17 1976-07-23 Minnesota Mining & Mfg Materiales de hoja termograficas y fototermograficas
US4725442A (en) 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS62281814A (ja) * 1986-05-27 1987-12-07 Teisan Seiyaku Kk 徐放化貼付剤
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5091188A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5114714A (en) 1990-11-29 1992-05-19 Sepracor, Inc. Methods of use and compositions of (r)-isoflurane and (r)-desflurane
US5114715A (en) 1990-11-29 1992-05-19 Sepracor Inc. Methods of use and compositions of (s)-isoflurane and (s)-desflurane
US5120561A (en) 1991-04-25 1992-06-09 American Lecithin Company Food composition and method
US5283372A (en) 1991-12-04 1994-02-01 Anaquest, Inc. Preparation of purified optical isomers of desflurane
US6007838A (en) 1995-06-07 1999-12-28 The United States Of America As Represented By The Secretary Of The Army Process for making liposome preparation
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
JP5210486B2 (ja) * 2002-10-11 2013-06-12 バクスター・インターナショナル・インコーポレイテッド ハロゲン化揮発性麻酔剤の静脈投与による、心臓保護および神経保護のための方法
MXPA06000803A (es) * 2003-09-10 2006-08-23 Cristalia Prod Quimicos Farm Composicion farmaceutica estable del compuesto de fluoroeter para uso anestesico, metodo para estabilizar un compuesto de fluoroeter, uso del agente estabilizador para evitar la degradacion de un compuesto de fluoroeter.
US20050079147A1 (en) 2003-10-14 2005-04-14 Bernard Delaey Wound healing compositions and uses
AU2007299738B2 (en) 2006-09-20 2013-03-28 The Board Of Regents Of The University Of Texas System Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
CN101522180A (zh) * 2006-09-20 2009-09-02 得克萨斯大学体系董事会 用于区域麻醉和/和疼痛缓解的递送挥发性麻醉剂的方法
JP2008288365A (ja) * 2007-05-17 2008-11-27 Mitsubishi Electric Corp 半導体装置
EP3581169A1 (en) 2008-01-22 2019-12-18 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
WO2009094460A2 (en) * 2008-01-22 2009-07-30 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
US7736537B1 (en) 2008-01-24 2010-06-15 Mainstream Engineering Corp. Replacement solvents having improved properties for refrigeration flushes
CN101977909A (zh) * 2008-03-18 2011-02-16 雷迪博士实验室有限公司 右兰索拉唑方法和多晶型物
EP2745692A1 (en) 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
US8533544B2 (en) * 2009-03-31 2013-09-10 Freescale Semiconductor, Inc. System for tree sequence testing of a device and method for tree sequence testing of a device in a test framework architecture
WO2010129686A1 (en) * 2009-05-05 2010-11-11 Vapogenix, Inc. Novel formulations of volatile anesthetics and methods of use for reducing inflammation
US8498853B2 (en) * 2009-07-20 2013-07-30 Exxonmobil Upstream Research Company Petrophysical method for predicting plastic mechanical properties in rock formations
CN101791291B (zh) * 2010-04-02 2011-12-28 徐州医学院 七氟醚静脉微乳剂及其制备方法
US9968540B2 (en) * 2011-06-24 2018-05-15 Vapogenix, Inc. Formulations and methods for treating dermatological disorders or diseases
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
WO2013016511A1 (en) * 2011-07-27 2013-01-31 University Of Miami Stable liquid formulations of volatile gas anesthetics
CN112933036A (zh) * 2013-03-15 2021-06-11 维普詹尼克斯公司 新型镇痛组合物

Also Published As

Publication number Publication date
US20210077423A1 (en) 2021-03-18
US9655867B2 (en) 2017-05-23
AU2022204105A1 (en) 2022-06-30
US20170231924A1 (en) 2017-08-17
US11304913B2 (en) 2022-04-19
US20200022928A1 (en) 2020-01-23
US10507189B2 (en) 2019-12-17
US20180250242A1 (en) 2018-09-06
WO2014143964A2 (en) 2014-09-18
CN105611921A (zh) 2016-05-25
AU2014227996A1 (en) 2015-10-08
DK2968214T3 (da) 2021-06-07
JP2022031534A (ja) 2022-02-18
AU2018264078A1 (en) 2018-12-06
CA3179312A1 (en) 2014-09-18
CA3179312C (en) 2025-07-08
WO2014143964A3 (en) 2014-11-20
US10071065B2 (en) 2018-09-11
EP2968214A4 (en) 2017-04-12
JP2020037574A (ja) 2020-03-12
EP3854389A1 (en) 2021-07-28
CA2906072C (en) 2023-01-10
CA2906072A1 (en) 2014-09-18
JP7410114B2 (ja) 2024-01-09
AU2014227996B2 (en) 2018-08-23
EP2968214A2 (en) 2016-01-20
CN112933036A (zh) 2021-06-11
US20160022603A1 (en) 2016-01-28
JP2016513727A (ja) 2016-05-16
JP6669645B2 (ja) 2020-03-18
AU2018264078B2 (en) 2020-05-28
US10688062B2 (en) 2020-06-23
CN113712911A (zh) 2021-11-30
AU2020220122A1 (en) 2020-09-03
JP2024026453A (ja) 2024-02-28
EP2968214B1 (en) 2021-03-10
ES2873964T3 (es) 2021-11-04

Similar Documents

Publication Publication Date Title
DK3342773T3 (da) Syk-hæmmere
DK3613453T3 (da) Fordamper
PL2968214T3 (pl) Nowe kompozycje przeciwbólowe
DK3077047T3 (da) Aramcholsalte
DK3052081T3 (da) Pastil
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK2956698T3 (da) Bindestrimler
DK2946640T3 (da) Langmuir-probe
EP2943489A4 (en) DEUTERATED MOMELOTINIB
FR3011475B1 (fr) Descendeur-assureur autobloquant
DE102013106534B8 (de) Chromatographiepipettenspitze
EP2991647A4 (en) DEUTERED AMLEXANOX
EP2970310A4 (en) 5-BROMO-indirubins
EP2853297A4 (en) kendama
DK3071227T3 (da) Fiskevaccine
DE112014001252A5 (de) Aufbissschiene
DK3086679T3 (da) Sportssko
DK2981168T3 (da) Laminitiskile
FI10343U1 (fi) Mittateippi
FI10138U1 (fi) Kelkkateltta
ES1078715Y (es) Mosquitera
DE112014005422A5 (de) Friktionsfalschdrallaggregat
BR112016000501A2 (pt) Nalador
ES1100380Y (es) Trompo